Cargando…

Immunogenicity of SARS inactivated vaccine in BALB/c mice

Severe acute respiratory syndrome (SARS) is a serious infectious threat to public health. To create a novel trial vaccine and evaluate its potency, we attempted to generate a SARS inactivated vaccine using SARS coronavirus (SARS-CoV) strain F69 treated with formaldehyde and mixed with Al(OH)(3). Thr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Sheng, Wang, Yi-Fei, Zhang, Mei-Ying, Liu, Xin-Jian, Zhang, Chuan-Hai, Liu, Shi-Sheng, Qian, Chui-Wen, Li, Jiu-Xiang, Lu, Jia-Hai, Wan, Zhuo-Yue, Zheng, Huan-Yin, Yan, Xin-Ge, Meng, Min-Jie, Fan, Jiang-lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112924/ https://www.ncbi.nlm.nih.gov/pubmed/15388253 http://dx.doi.org/10.1016/j.imlet.2004.06.014

Ejemplares similares

Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain
por: Zhang, Chuan-hai, et al.
Publicado: (2005)

Immune responses and histopathological changes in rabbits immunized with inactivated SARS coronavirus
por: Zhang, Chuan-hai, et al.
Publicado: (2008)

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
por: Wang, Wen-Xin, et al.
Publicado: (2022)

The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice
por: Li, Feng, et al.
Publicado: (2019)

Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice
por: Zhao, Fu-jie, et al.
Publicado: (2022)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
por: Eroglu, Erdal, et al.
Publicado: (2016)

Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
por: Han, Xiaoxu, et al.
Publicado: (2022)

Oral vaccination with Trichinella spiralis DNase II DNA vaccine delivered by attenuated Salmonella induces a protective immunity in BALB/c mice
por: Qi, Xin, et al.
Publicado: (2018)

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice
por: Hosseini, Zahra Sadat, et al.
Publicado: (2018)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models
por: Wang, Ze-Jun, et al.
Publicado: (2020)

Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice
por: Sundaram, Appavu K., et al.
Publicado: (2021)

Pore-forming alpha-hemolysin efficiently improves the immunogenicity and protective efficacy of protein antigens
por: Zou, Jin-Tao, et al.
Publicado: (2021)

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
por: Wu, Zhi-Wei, et al.
Publicado: (2023)

Solar inactivated Salmonella Typhimurium induces an immune response in BALB/c mice
por: Ssemakalu, Cornelius C., et al.
Publicado: (2021)

Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice
por: Kaur, Sukhbir, et al.
Publicado: (2016)

Immunogenicity of Multiepitope Vaccine Candidate against Toxoplasma gondii Infection in BALB/c Mice
por: HAJISSA, Khalid, et al.
Publicado: (2018)

Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients
por: Zhang, Yue-Miao, et al.
Publicado: (2022)

The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
por: Yang, Lei, et al.
Publicado: (2023)

Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
por: He, Chuan-Yu, et al.
Publicado: (2022)

Fixing tacks induced bladder erosion and recurrent stones following laparoscopic inguinal hernia repair: a case report
por: Liu, Wan-Zhang, et al.
Publicado: (2020)

Immunogenicity of an Inactivated Canine Adenovirus Type 1 Vaccine for Foxes
por: Fu, Yang, et al.
Publicado: (2022)

Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2019)

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
por: Kim, Eun, et al.
Publicado: (2014)

Immunogenicity Assessment of Rift Valley Fever Virus Virus-Like Particles in BALB/c Mice
por: Li, Yuetao, et al.
Publicado: (2020)

Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice
por: Mao, Qunying, et al.
Publicado: (2012)

Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
por: Zhou, Yan, et al.
Publicado: (2023)

Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus
por: Zhang, Yuntao, et al.
Publicado: (2022)

Molecular identification of Trichinella spiralis nudix hydrolase and its induced protective immunity against trichinellosis in BALB/c mice
por: Long, Shao Rong, et al.
Publicado: (2014)

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
por: Yang, Lei, et al.
Publicado: (2023)

Clinical significance of intrapancreatic choledochal cyst excision in surgical management of type I choledochal cyst
por: Fan, Fei, et al.
Publicado: (2018)

Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine
por: Qin, Ede, et al.
Publicado: (2006)

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
por: Xiang, Tiandan, et al.
Publicado: (2021)

Protective role of thymoquinone in sepsis-induced liver injury in BALB/c mice
por: Wang, Fei, et al.
Publicado: (2019)

Strikingly poor CD8(+) T cell immunogenicity of vaccinia virus strain MVA in BALB/c mice
por: Russell, Tiffany A., et al.
Publicado: (2014)

Evaluation of the immunogenicity and efficacy of a chimeric OMP25–OMP31 antigen in BALB/c mice
por: Mohammadi, Yahya
Publicado: (2021)

Molecular identification of Phlebotomus kandelakii apyrase and assessment of the immunogenicity of its recombinant protein in BALB/c mice
por: Fayaz, Shima, et al.
Publicado: (2023)

Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
por: Yin, Di, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_koss52ro95bdiipj6214dcant2